Hypothesis\n\nThe inactive X chromosome (Xi) acts as an epigenetic capacitor whose age‑dependent loss of silencing drives stochastic gene escape, innate immune activation via cytosolic dsRNA, and inflammaging. Stabilizing Xi by enhancing XIST‑mediated recruitment of H3K27me3 will reduce epigenetic noise, lower cGAS‑STING signaling, and extend lifespan independently of gonadal hormones.\n\n## Mechanistic Rationale\n\n1. Epigenetic noise → dsRNA – Reactivation of Xi loci produces convergent transcription from previously silenced regions, generating double‑stranded RNA that activates cGAS‑STING and NF‑κB pathways ([4]).\n2. Xi stability as a dosage‑independent longevity factor – XX mice outlive XY mice even when gonads are swapped, showing that X number, not hormones, sets baseline lifespan ([1]).\n3. Centromere‑proximal heterochromatin – Enrichment of H3K27me3 at Xi correlates with low methylation variability and centenarian longevity ([2]); age‑related loss of this mark precedes transcriptional dysregulation ([3]).\n\n## Novel Insight\n\nWe propose that Xi‑derived dsRNA is not merely a byproduct but a causal trigger of chronic innate immune activation. By reinforcing XIST‑dependent heterochromatin (e.g., via transgenic overexpression of the XIST repeat domain or pharmacologic activation of EZH2), we suppress dsRNA formation, thereby breaking the link between epigenetic noise and inflammaging.\n\n## Testable Predictions\n\n- Prediction 1: In XX mice, inducible overexpression of XIST’s repeat A region will increase H3K27me3 on Xi, reduce age‑associated methylation variability, and decrease cytosolic dsRNA levels measured by anti‑dsRNA immunostaining.\n- Prediction 2: These mice will exhibit lower serum IL‑6, TNF‑α, and cGAS‑STING activation markers compared with littermate controls at 18 months of age.\n- Prediction 3: Median lifespan will be extended by ≥15% relative to controls, an effect that persists in gonadectomized animals, demonstrating hormone independence.\n- Prediction 4: XY mice carrying an extra X chromosome (XXY) that also receives the XIST transgene will show additive lifespan extension, supporting a dose‑response of Xi stability.\n\n## Falsification\n\nIf XIST overexpression fails to reduce Xi‑derived dsRNA or does not improve lifespan despite confirmed heterochromatin gains, the hypothesis that Xi‑driven innate immune activation is a primary aging driver would be refuted, prompting alternative mechanisms such as hormone‑mediated effects.\n\n## Experimental Approach\n\n- Generate a Cre‑inducible XIST repeat‑A transgene knocked into the Rosa26 locus.\n- Cross with ubiquitously active ERT2‑Cre mice; administer tamoxifen at 3 months.\n- Assess Xi H3K27me3 by CUT&Tag, RNA‑FISH for XIST, dsRNA by J2 antibody staining, and inflammaging markers.\n- Monitor survival cohorts (n≥50 per genotype) under standard conditions.\n\nBy directly coupling Xi epigenetic reinforcement to innate immune readouts and longevity, this framework converts the correlative observations of X‑chromosome epigenetics into a causal, interventional test of the ‘longevity chromosome’ hypothesis.